Announcements

Arshia Sarkhani, Chief Marketing Officer and Director at Strive, Inc., was reported as acquiring 9,191 Performance Stock Units tied to Class A Common Stock on August 7, 2026, according to a beneficial ownership statement filed with the SEC on August 10, 2026.

Dole plc filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 10, 2026, covering the quarterly period ended June 30, 2026.

JBG SMITH Properties filed its quarterly report on Form 10-Q with the SEC on August 10, 2026, covering the quarter and six months ended June 30, 2026, disclosing a net loss attributable to common shareholders of $59.2 million for the second quarter and $77.9 …

Strive, Inc. filed its Form 10-Q for the quarterly period ended June 30, 2026 with the U.S. Securities and Exchange Commission on August 10, 2026, reporting a net loss of $523.5 million for the six months ended June 30, 2026.

Strive, Inc. filed a Current Report on Form 8-K with the SEC on August 10, 2026, disclosing that it issued a press release announcing its financial results for the quarter ended June 30, 2026.

Freedom Holding Corp. filed its Form 10-Q for the quarterly period ended June 30, 2026 with the U.S. Securities and Exchange Commission, reporting net income of $31,660 thousand and total assets of $14,046,883 thousand for the three months ended June 30, 2026.

Silence Therapeutics plc (Nasdaq: SLN), a clinical-stage RNA medicine company incorporated in England and Wales, filed its quarterly report on Form 10-Q for the period ended June 30, 2026, with the U.S. Securities and Exchange Commission on August 10, 2026.